“Efficacy and safety of Janus Kinase Inhibitors versus Traditional DMARDs in moderate to severe Rheumatoid Arthritis” (2025) Revista Eletrônica Acervo Científico, 25, p. e20772. doi:10.25248/reac.e20772.2025.